Pharmaceutical Drug Injury
Drugs with deadly or dangerous side effects often make it to the market because their potential dangers were not anticipated during clinical trials. These drugs are classified as defective drugs and have been identified by the FDA as having dangerous side effects that may outweigh whatever benefits they may have. Such an FDA classification often leads to drug recalls, personal injuries and lawsuits against drug companies.
Even if you feel you are not ready to file a suit, consult one of our qualified lawyers as soon as possible so that you will know your options. We do not charge any fees upfront. In fact, we will only charge attorney’s fees if we obtain a financial settlement for you. If you don’t win, we won’t get paid a legal fee. Call us today for your free case evaluation.
CURRENT LIST OF PHARMACEUTICAL DRUG INJURY CLAIMS
Invokana is a new medication used to treat Type II diabetes. A large number of persons using this medication have had diabetic ketoacidosis (DKA) requiring hospitalization as well as amputation. We are looking at these serious injury cases.
Taxotere is a popular chemotherapy used to treat breast cancer. We are looking at cases where there was permanent hair loss after use.
Zofran is used to help combat nausea during pregnancy. We are looking at cases where women were using this drug in the first trimester of pregnancy and gave birth to an infant with serious birth defects– primarily heart defects and skeletal defects.
This is a popular prescription and over the counter medication used to treat reflux disease and heart burn. It has recently been linked to certain types of cancer including those of the liver, stomach, esophagus, colon, and kidney. We are looking at claims where people used the product and were diagnosed with cancer.
A widely prescribed blood pressure medication, it has been linked to certain types of cancers after use including liver, stomach, colon, and kidney. If the drug was used after January 2015 and the user was diagnosed with one of these types of cancer, we would like to investigate.